Skip to main content
Caplight Logo









Persperion Diagnostics

Persperion Diagnostics

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://persperion.com/

Last Round

Angel

Jun 25, 2026

Total Funding Raised

$4.45M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Persperion Diagnostics is a medical device company that develops non-invasive, touch-based sweat biosensing technology for glucose monitoring and personal health management.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors

Business Model

B2C

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Non-AI

Keywords

non-invasive glucose monitoringcontinuous glucose monitorCGMsweat biosensingdiabetes managementneedle-free testingbloodless glucose testmedical deviceelectrochemical biosensordiagnostic hardwarerazor and bladeshealth IoTpersonal health managementwearable diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Persperion Diagnostics Comparables

Compare Persperion Diagnostics with similar companies based on industry and business-model similarity.

Persperion Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Afon Technology
82%
PKvitality
78%
GraphWear Technologies Inc.
78%

Persperion Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelJun 25, 2026
Convertible DebtMay 1, 2025
SeedNov 28, 2023

Persperion Diagnostics Investors

Notable investors and investment history

Persperion Diagnostics investors
InvestorRounds
Cornucopian CapitalSeed
Foothill VenturesSeed
Linear CapitalConvertible Debt
MiraclePlusConvertible Debt, Seed
Food & Health AngelsAngel
NSF I-Corps ProgramSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 25, 2026

    Raised an Angel round with Food & Health Angels.

  • May 1, 2025

    $450K round with participation from Linear Capital and MiraclePlus.

Persperion Diagnostics Filings

Explore SEC and related filing metadata, where available.

Persperion Diagnostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Persperion Diagnostics's valuation, stock price, and market status.

Is Persperion Diagnostics a public or private company?

Persperion Diagnostics is a private company.

What is the current stock price of Persperion Diagnostics?

Persperion Diagnostics is a private company with no public stock price. No recent secondary market data is available.

How much is Persperion Diagnostics worth (valuation)?

Valuation information for Persperion Diagnostics is not publicly available.

Can I buy Persperion Diagnostics stock?

Persperion Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Persperion Diagnostics's last funding round?

Persperion Diagnostics's most recent funding round was Angel on June 25, 2026.

Who are the main investors in Persperion Diagnostics?

Key investors in Persperion Diagnostics include Cornucopian Capital, Foothill Ventures, Linear Capital, MiraclePlus, Food & Health Angels.

Will Persperion Diagnostics IPO soon?

No public IPO plans have been announced for Persperion Diagnostics.

How can I track Persperion Diagnostics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Persperion Diagnostics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Year Founded2022
Last FundingJun 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?